508
Egan BM, Li J, Hutchison FN, Ferdinand KC. Hypertension in the United States 1999–2012: progress
toward healthy people 2020 goals. Circulation 20 Oct 2014; pii: CIRCULATIONAHA.114.010676.
Eschenhagen T, Blankenberg S. Personalized therapy in cardiology. Biomarkers, pharmacogenetics
and therapy of monogenic diseases. Internist (Berl). 2013;54:147–8, 150–2, 154.
Ferrandi M, Molinari I, Torielli T, et al. Adducin- and ouabain-related gene variants predict the
antihypertensive activity of rostafuroxin, part 1: experimental studies. Sci Trans Med.
2010;2:59ra86.
Floras JS. Blood pressure variability: a novel and important risk factor. Can J Cardiol.
2013;29:557–63.
Franceschini N, Fox E, Zhang Z, et al. Genome-wide association analysis of blood-pressure traits
in African-ancestry individuals reveals common associated genes in African and non-African
populations. Am J Hum Genet. 2013;93:545–54.
Furie B. Do pharmacogenetics have a role in the dosing of vitamin K antagonists? N Engl J Med.
2013;369:2345–6.
Graham MJ, Lee RG, Bell III TA, et al. Antisense oligonucleotide inhibition of apolipoprotein
C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans. Circ Res.
2013;112:1479–90.
Hakonarson H, Thorvaldsson S, Helgadottir A, et al. Effects of a 5-lipoxygenase–activating pro-
tein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial.
JAMA. 2005;293:2245–56.
Hamlyn JM, Linde CI, Gao J, et al. Neuroendocrine humoral and vascular components in the pres-
sor pathway for brain angiotensin II: a new axis in long term blood pressure control. PLoS One.
2014;9(9):e108916.
Iakoubova OA, Tong CH, Rowland CM, et al. Association of the Trp719Arg polymorphism in
kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective
trials: the CARE and WOSCOPS trials. J Am Coll Cardiol. 2008;51:435–43.
Iqbal J, Serruys PW. Revascularization strategies for patients with stable coronary artery disease. J
Intern Med. 2014;276:336–51.
Jain KK. Applications of biotechnology in cardiovascular therapeutics. New York: Springer; 2011.
Johnson JA, Boerwinkle E, Zineh I, et al. Pharmacogenomics of antihypertensive drugs: rationale
and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study.
Am Heart J. 2009;157:442–9.
Jørgensen AB, Frikke-Schmidt R, Nordestgaard BG, Tybjærg-Hansen A. Loss-of-function muta-
tions in APOC3 and risk of ischemic vascular disease. N Engl J Med. 2014;371:32–41.
Kathiresan S, Melander O, Anevski D, et al. Polymorphisms associated with cholesterol and risk
of cardiovascular events. N Engl J Med. 2008;358:1240–9.
Kim K, Bolotin E, Theusch E, et al. Prediction of LDL cholesterol response to statin using tran-
scriptomic and genetic variation. Genome Biol. 2014;15:460.
Koenig W, Khuseyinova N, Lowel H, et al. Lipoprotein-associated phospholipase A2 adds to risk
prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged
men from the general population: results from the 14-year follow-up of a large cohort from
southern Germany. Circulation. 2004;110:1903–8.
Krueger MW, Schulze WH, Rhode KS, et al. Towards personalized clinical in-silico modeling of
atrial anatomy and electrophysiology. Med Biol Eng Comput. 2013;51:1251–60.
Lanzani C, Citterio L, Glorioso N, et al. Adducin- and ouabain-related gene variants predict the
antihypertensive activity of rostafuroxin, part 2: Clinical studies. Sci Transl Med. 2010;2:59ra87.
Liggett SB, Mialet-Perez J, Thaneemit-Chen S, et al. A polymorphism within a conserved beta(1)-
adrenergic receptor motif alters cardiac function and beta-blocker response in human heart
failure. Proc Natl Acad Sci U S A. 2006;103:11288–93.
Maglo KN, Rubinstein J, Huang B, Ittenbach RF. BiDil in the clinic: an interdisciplinary investigation
of physicians’ prescription patterns of a race-based therapy. AJOB Empir Bioeth. 2014;5:37–52.
Pirmohamed M, Burnside G, Eriksson N, et al. A randomized trial of genotype-guided dosing of
warfarin. N Engl J Med. 2013;369:2294–303.
14 Personalized Management of Cardiovascular Disorders